Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2015

01.04.2015 | Topic Review

Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature

verfasst von: Ana-Maria Vranceanu, Vanessa L. Merker, Elyse R. Park, Scott R. Plotkin

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this research is to identify, within a systematic review, aspects of quality of life (QoL) that are adversely affected in children and adolescents with neurofibromatosis (NF), and to report predictors of quality of life in this population. Published reports of original research were included if they described QoL in children and/or adolescents with NF, and met methodological quality according to a list of predefined criteria. Seven studies conducted between 2006 and 2013 met inclusion criteria. All seven studies examined patients with NF1 and reported that these patients have lower general QoL compared to population norms. Parents’ proxy ratings of QoL were generally lower than children’s self-report ratings. By parent proxy, familial NF1 was a strong protective factor for QoL, while the opposite was found by child report. By parent proxy, male sex was significantly associated with lower scores on the parental time impact of QoL. Skin-related QoL was only slightly altered in this population, vision-specific QoL was impacted only in patients with vision loss. The majority of findings regarding predictors of QoL in children with NF1 were weak, due to a lack of studies, heterogeneity of samples, and heterogeneity of measurements/predictors assessed. Future studies should examine more comprehensively the psychosocial factors affecting the NF population, especially in young patients with NF2 and schwannomatosis, who have been neglected in prior research. The use of consistent QoL measures is preferred to allow better comparison among studies and conditions. Interventions, including comprehensive mind–body treatments, are warranted to address impaired QoL in children and adolescents with NF1.
Literatur
1.
Zurück zum Zitat Lu-Emerson C, Plotkin SR (2009) The Neurofibromatoses. Part 1: NF1. Rev Neurol Dis 6:E47–E53PubMed Lu-Emerson C, Plotkin SR (2009) The Neurofibromatoses. Part 1: NF1. Rev Neurol Dis 6:E47–E53PubMed
2.
Zurück zum Zitat Lu-Emerson C, Plotkin SR (2009) The neurofibromatoses. Part 2: NF2 and schwannomatosis. Rev Neurol Dis 6:E81–E86PubMed Lu-Emerson C, Plotkin SR (2009) The neurofibromatoses. Part 2: NF2 and schwannomatosis. Rev Neurol Dis 6:E81–E86PubMed
3.
Zurück zum Zitat Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327–332CrossRefPubMed Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327–332CrossRefPubMed
4.
Zurück zum Zitat Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71–76CrossRefPubMed Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71–76CrossRefPubMed
5.
Zurück zum Zitat Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L (2008) Evidence of a four hit mechanism involving SMARCB1 and NF2 in schanoomatosis associated schwannomas. Hum Mutat 29(2):227–231CrossRefPubMed Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L (2008) Evidence of a four hit mechanism involving SMARCB1 and NF2 in schanoomatosis associated schwannomas. Hum Mutat 29(2):227–231CrossRefPubMed
6.
Zurück zum Zitat Jacoby LB, Jones D, David K, Kronn D, Short PM, Gusella J, MacCollin M (1997) Molecular analyses of the NF-2 tumor supresor gene in schwannomatosis. AJHG 61(7):1293–1302CrossRef Jacoby LB, Jones D, David K, Kronn D, Short PM, Gusella J, MacCollin M (1997) Molecular analyses of the NF-2 tumor supresor gene in schwannomatosis. AJHG 61(7):1293–1302CrossRef
7.
Zurück zum Zitat Nguyen R, Dombi E, Widemann BC, Solomon J, Fuensterer C, Kluwe L, Friedman JM, Mautner VF (2012) Growth dynamics of plexiform neurofibromas: a retrospective cohort of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis. doi:10.1186/1750-1172-7-75 Nguyen R, Dombi E, Widemann BC, Solomon J, Fuensterer C, Kluwe L, Friedman JM, Mautner VF (2012) Growth dynamics of plexiform neurofibromas: a retrospective cohort of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis. doi:10.​1186/​1750-1172-7-75
8.
Zurück zum Zitat Vranceanu AM, Merker VL, Park E, Plotkin SR (2013) Quality of Life among adult patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: a systematic review of the literature. J Neurooncol 114(3):257–262CrossRefPubMed Vranceanu AM, Merker VL, Park E, Plotkin SR (2013) Quality of Life among adult patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: a systematic review of the literature. J Neurooncol 114(3):257–262CrossRefPubMed
9.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097CrossRefPubMedCentralPubMed Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Kuijpers T, van der Windt DA, van der Heijden GJ, Bouter LM (2004) Systematic review of prognostic cohort studies on shoulder disorders. Pain 109:420–431CrossRefPubMed Kuijpers T, van der Windt DA, van der Heijden GJ, Bouter LM (2004) Systematic review of prognostic cohort studies on shoulder disorders. Pain 109:420–431CrossRefPubMed
11.
Zurück zum Zitat Scholten-Peeters GG, Verhagen AP, Bekkering GE, van der Windt DA, Barnsley L, Oostendorp RA, Hendriks EJ (2003) Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain 104:303–322CrossRefPubMed Scholten-Peeters GG, Verhagen AP, Bekkering GE, van der Windt DA, Barnsley L, Oostendorp RA, Hendriks EJ (2003) Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain 104:303–322CrossRefPubMed
12.
Zurück zum Zitat Ariens GA, van Mechelen W, Bongers PM, Bouter LM, van der Wal G (2000) Physical risk factors for neck pain. Scand J Work Environ Health 26:7–19CrossRefPubMed Ariens GA, van Mechelen W, Bongers PM, Bouter LM, van der Wal G (2000) Physical risk factors for neck pain. Scand J Work Environ Health 26:7–19CrossRefPubMed
13.
Zurück zum Zitat Garwood MM, Bernacki JM, Fine KM, Hainsworth KR, Davies WH, Klein-Tasman BP. (2006) Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1. Pain Research and Treatment 2012:Article ID 975364 Garwood MM, Bernacki JM, Fine KM, Hainsworth KR, Davies WH, Klein-Tasman BP. (2006) Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1. Pain Research and Treatment 2012:Article ID 975364
14.
Zurück zum Zitat Oostenbrink R, Spong K, de Goede-Bolder A, Landgraf JM, Raat H, Moll HA (2007) Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants. J Pediatr 151:182–186CrossRefPubMed Oostenbrink R, Spong K, de Goede-Bolder A, Landgraf JM, Raat H, Moll HA (2007) Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants. J Pediatr 151:182–186CrossRefPubMed
16.
Zurück zum Zitat Wolkenstein P, Rodriguez D, Ferkal S, Gravier H, Buret V, Algans N, Simeoni MC, Bastuji-Garin S (2008) Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases. British Journal of Dematology 160:844–848CrossRef Wolkenstein P, Rodriguez D, Ferkal S, Gravier H, Buret V, Algans N, Simeoni MC, Bastuji-Garin S (2008) Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases. British Journal of Dematology 160:844–848CrossRef
17.
Zurück zum Zitat Krab LC, Oostenbring R, de Goede-Bolder A, Aarsen FK, Elgersma Y, Moll HA (2009) Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. J Pediatr 154:420–425CrossRefPubMed Krab LC, Oostenbring R, de Goede-Bolder A, Aarsen FK, Elgersma Y, Moll HA (2009) Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. J Pediatr 154:420–425CrossRefPubMed
18.
Zurück zum Zitat Graf A, Landolt MA, Capone Mori A, Boltshauser E (2006) Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. J Pediatr 149:348–353CrossRefPubMed Graf A, Landolt MA, Capone Mori A, Boltshauser E (2006) Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. J Pediatr 149:348–353CrossRefPubMed
19.
Zurück zum Zitat Spuijbroek AT, Oostenbring R, Landgraf JM, Rietveld E, de Goede-Bolder A, van Beeck EF, van Baar M, Raat H, Moll HA (2011) Health-related quality of life in preschool children in five health conditions. Qual Life Res 20:779–786CrossRefPubMedCentralPubMed Spuijbroek AT, Oostenbring R, Landgraf JM, Rietveld E, de Goede-Bolder A, van Beeck EF, van Baar M, Raat H, Moll HA (2011) Health-related quality of life in preschool children in five health conditions. Qual Life Res 20:779–786CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Varni JW, Seid M, Kurtin PS (2001) PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory verion 4.0 generic core scales in healthy and patient populations. Med Care 39(8):800–812CrossRefPubMed Varni JW, Seid M, Kurtin PS (2001) PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory verion 4.0 generic core scales in healthy and patient populations. Med Care 39(8):800–812CrossRefPubMed
21.
Zurück zum Zitat Verrips EGH, Vogels TGC, Koopman HM, Theunissen NCM, Kamphuis RP, Fekkes M, Wit JM, Verloove-Vanhorick S (2011) Meauring health-related quality of life in a child population. Eur J Pub Health 9(3):188–193CrossRef Verrips EGH, Vogels TGC, Koopman HM, Theunissen NCM, Kamphuis RP, Fekkes M, Wit JM, Verloove-Vanhorick S (2011) Meauring health-related quality of life in a child population. Eur J Pub Health 9(3):188–193CrossRef
22.
Zurück zum Zitat Landgraf JM, Vogel I, Oostenbrink R, van Baar ME, Raat H (2013) Parent-reported health outcomes in infants/toddlers: measurement properties and clinical validity of the ITQOL-SF47. Qual Life Res 22(3):635–646CrossRefPubMed Landgraf JM, Vogel I, Oostenbrink R, van Baar ME, Raat H (2013) Parent-reported health outcomes in infants/toddlers: measurement properties and clinical validity of the ITQOL-SF47. Qual Life Res 22(3):635–646CrossRefPubMed
23.
Zurück zum Zitat Baars RM, Atherton CI, Koopman HM, Bullinger M, Power M (2005) The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents. Health Qual Life Outcomes 3:70CrossRefPubMedCentralPubMed Baars RM, Atherton CI, Koopman HM, Bullinger M, Power M (2005) The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents. Health Qual Life Outcomes 3:70CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Hullman SE, Ryan JL, Ramsey RR, Chaney JM, Mullins LL (2011) Measure of General Pediatric Quality of Life. Arthritis Res Care 63(S11):S420–S430CrossRef Hullman SE, Ryan JL, Ramsey RR, Chaney JM, Mullins LL (2011) Measure of General Pediatric Quality of Life. Arthritis Res Care 63(S11):S420–S430CrossRef
25.
26.
Zurück zum Zitat Lewis-Jones MS, Finlay AY (1995) The children’s dermatology life quality index (CDLQI): intial validation and practical use. Br J Dermatol 132(6):942–949CrossRefPubMed Lewis-Jones MS, Finlay AY (1995) The children’s dermatology life quality index (CDLQI): intial validation and practical use. Br J Dermatol 132(6):942–949CrossRefPubMed
27.
Zurück zum Zitat Eiser C, Varni JW (2013) Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr 172(10):1299–1304CrossRefPubMed Eiser C, Varni JW (2013) Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr 172(10):1299–1304CrossRefPubMed
28.
Zurück zum Zitat White-Konig M, Arnaud C, Dickinson HO, Thyen U et al (2007) Determinants of child-parent agreement in quality of life reports: a european study of children with cerebral palsy. Pediatrics 120(4):804–814CrossRef White-Konig M, Arnaud C, Dickinson HO, Thyen U et al (2007) Determinants of child-parent agreement in quality of life reports: a european study of children with cerebral palsy. Pediatrics 120(4):804–814CrossRef
29.
Zurück zum Zitat Youssef NN, Langseder AL, Verga BJ, Mones RL, Rosh JR (2005) Chronic childhood constipation is associated with impaired quality of life: a case controlled study. J Ped Gastroent and Nutrition 41:56–60CrossRef Youssef NN, Langseder AL, Verga BJ, Mones RL, Rosh JR (2005) Chronic childhood constipation is associated with impaired quality of life: a case controlled study. J Ped Gastroent and Nutrition 41:56–60CrossRef
30.
Zurück zum Zitat Denny S, de Silva M, Fleming T, Clark T, Merry S, Ameratunga S, Milfont T, Farrant B, Fortune SA (2014) The prevalence of chronic health conditions impacting on daily functioning and the assocaition with emotional well-being among a national sample of highschool students. J Adol Health 54(4):410–415CrossRef Denny S, de Silva M, Fleming T, Clark T, Merry S, Ameratunga S, Milfont T, Farrant B, Fortune SA (2014) The prevalence of chronic health conditions impacting on daily functioning and the assocaition with emotional well-being among a national sample of highschool students. J Adol Health 54(4):410–415CrossRef
31.
Zurück zum Zitat Jamieson N, Fitzgerald D, Singh-Grewal D, Hanson CS, Craig JC, Tong A (2014) Children’s experiences of cystic fibrosis: a systematic review of qualitative studies. Pediatrics 133(6):1683–1697CrossRef Jamieson N, Fitzgerald D, Singh-Grewal D, Hanson CS, Craig JC, Tong A (2014) Children’s experiences of cystic fibrosis: a systematic review of qualitative studies. Pediatrics 133(6):1683–1697CrossRef
32.
Zurück zum Zitat Noll RB, Reiter-Putill J, Moore DB, Schorry EK, Lovell AM, Vannatta K, Gerhardt CA (2007) Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet 143(19):2261–2273CrossRef Noll RB, Reiter-Putill J, Moore DB, Schorry EK, Lovell AM, Vannatta K, Gerhardt CA (2007) Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet 143(19):2261–2273CrossRef
33.
Zurück zum Zitat Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B (2012) Social-emotinal functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationship with cognitive, disease and environmental variables. J Ped Psychol 37(7):713–724CrossRef Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B (2012) Social-emotinal functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationship with cognitive, disease and environmental variables. J Ped Psychol 37(7):713–724CrossRef
34.
Zurück zum Zitat Vranceanu AM, Merker V, Plotkin S, Park E (2014) The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis. Results from a pilot trial. J Neurooncol 120(22):3554–3561 Vranceanu AM, Merker V, Plotkin S, Park E (2014) The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis. Results from a pilot trial. J Neurooncol 120(22):3554–3561
35.
Zurück zum Zitat Wolters PL, Martin S, Merker VL, Gardner KL, Hingtgen CM, Tonsgard JH, Schorry EK, Baldwin A, REiNS International Collaboration (2013) Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. Neurology 81(21 Suppl 1):S6–S14CrossRefPubMedCentralPubMed Wolters PL, Martin S, Merker VL, Gardner KL, Hingtgen CM, Tonsgard JH, Schorry EK, Baldwin A, REiNS International Collaboration (2013) Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. Neurology 81(21 Suppl 1):S6–S14CrossRefPubMedCentralPubMed
Metadaten
Titel
Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature
verfasst von
Ana-Maria Vranceanu
Vanessa L. Merker
Elyse R. Park
Scott R. Plotkin
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2015
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1725-1

Weitere Artikel der Ausgabe 2/2015

Journal of Neuro-Oncology 2/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.